We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for leniolisib (Ballia Holdings Pty Ltd)
Active ingredients
leniolisib
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
Treatment of activated phosphoinositide 3-kinase delta syndrome (APDS) in adults and adolescents 12 years of age or older
Therapeutic area
Immunology